Litigation Details for Fresenius Kabi USA, LLC v. Baxter Healthcare Corporation (D. Del. 2021)
✉ Email this page to a colleague
Fresenius Kabi USA, LLC v. Baxter Healthcare Corporation (D. Del. 2021)
| Docket | ⤷ Sign Up | Date Filed | 2021-07-16 |
| Court | District Court, D. Delaware | Date Terminated | 2022-05-05 |
| Cause | 35:271 Patent Infringement | Assigned To | Maryellen Noreika |
| Jury Demand | None | Referred To | |
| Patents | 7,828,787; 7,857,802; 8,118,802; 8,162,915 | ||
| Link to Docket | External link to docket | ||
Small Molecule Drugs cited in Fresenius Kabi USA, LLC v. Baxter Healthcare Corporation
The small molecule drug covered by the patents cited in this case is ⤷ Sign Up .
Details for Fresenius Kabi USA, LLC v. Baxter Healthcare Corporation (D. Del. 2021)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 0000-00-00 | External link to document | |||
| 2021-07-16 | 1 | Complaint | United States Patent Nos. 7,828,787 (“the ’787 patent”); 7,857,802 (“the ’7,802 patent”); 8,118,802 (…claims of the Patents-in-Suit. COUNT I FOR INFRINGEMENT OF U.S. PATENT NO. 7,828,787 BY … (“the ’8,802 patent”); and 8,162,915 (“the ’915 patent”) (collectively, “the Patents-in-Suit”). This… BACKGROUND The Patents-in-Suit 27. The ’787 Patent, entitled “Connector for packaging…inventors assigned the ’787 Patent to Fresenius Kabi Deutschland GmbH. The ’787 Patent is listed in the Orange | External link to document |
| 2021-07-16 | 4 | Patent/Trademark Report to Commissioner of Patents | the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) US 7,828,787 B2 ;US 7,857,802 …July 2021 5 May 2022 1:21-cv-01040 835 Patent - Abbreviated New Drug Application(ANDA) None | External link to document |
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
